Trial Profile
Randomized controlled Phase 3 trial of all-trans retinoic acid(ATRA) versus new synthetic retinoid Tamibarotene(Am80) for maintenance therapy in patients with adult acute promyelocytic leukemia: Japan Adult Leukemia Study Group (JALSG) APL204 Study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Jun 2019
Price :
$35
*
At a glance
- Drugs Tamibarotene (Primary) ; Tretinoin
- Indications Acute promyelocytic leukaemia
- Focus Registrational; Therapeutic Use
- 04 Dec 2018 Results presented at the 60th Annual Meeting and Exposition of the American Society of Hematology
- 12 Dec 2017 Results presented at the 59th Annual Meeting and Exposition of the American Society of Hematology
- 10 Dec 2012 Primary endpoint 'Relapse-free-survival-rate' has not been met.